U.S. Markets open in 1 hr 55 mins

Neutra Corp. Adds Prominent Physician to Staff; to Focus on Growing Sports Medicine/Nutrition Markets

Sugar Land, TX, April 10, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Neutra Corp. (NTRR) has made a significant addition to its staff that will help the company better tap the rapidly expanding sports performance medicine market. Dr. Scott E. Cherry, DO, MPH, FACOEM, brings considerable experience to his newly-created advisory role. Dr. Cherry has honed his considerable skills in a variety of medical and executive positions spanning the U.S. Army and Navy, several Fortune 500 corporations, and major health care facilities over the past 20 years.

With Neutra Corp., Dr. Cherry will continue his recent work designing tailored medical programs and services focused on human performance. He has previously served as a consulting physician for several human and sports performance clients and institutions. 

“This is a big addition for Neutra Corp.,” said Sydney Jim, Neutra Corp. president and CEO. “Scott has the capability to help our clients achieve more with their bodies and for us to accomplish more as a company. He has a great passion for sports and performance medicine and is a true expert in the field. With his considerable expertise and relationships he has built over his successful career, we’re expecting Neutra Corp. to make considerable leaps forward with his help.” 

Sports performance medicine and nutrition have been a strong focus for Neutra Corp. since Jim became CEO. The company has been actively searching for a top practioner to serve in a consulting and advisory role. 

The U.S. Department of Labor Statistics found that one in five Americans are active in a sport activity on any given day. The current U.S. population is more than 330 million people, meaning some 66 million people across the country are playing some sort of sport or exercising each day. Many of these consumers are looking for ways to improve their performance through medicine and nutrition geared specifically for sports-minded individuals. 

With Dr. Cherry on board, the company can now aggressively target the promising sports nutrition market, a segment that could top the $24 billion mark within the next six years, doubling current levels. Sports nutrition includes dietary supplements and energy products. Meanwhile, spending on improving sports performance is expected to reach $11 billion by 2023. 


Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: This news release contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, including statements that include the words “believes,” “expects,” “anticipate” or similar expressions. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements of the company to differ materially from those expressed or implied by such forward-looking statements.

Sydney Jim